A review of potential neuropathological changes associated with ketamine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A review of potential neuropathological changes associated with ketamine

Published:2022-05-08 Issue:6 Volume:21 Page:813-831
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Nogo Danica¹,Nazal Hana¹²,Song Yuetong¹³,Teopiz Kayla M.¹³⁴,Ho Roger⁵⁶,McIntyre Roger S.¹³⁴,Lui Leanna M.W.¹³,Rosenblat Joshua D.¹³⁴

Affiliation:

1. Mood Disorders Psychopharmacology Unit, University Health Network, Ontario, Canada

2. McMaster University, Ontario, Canada

3. University of Toronto, Ontario, Canada

4. Brain and Cognition Discovery Foundation, Ontario, Canada

5. Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

6. Institute for Health Innovation and Technology (Ihealthtech), National University of Singapore, Singapore

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2022.2071867

Reference102 articles.

1. Cross-national epidemiology of DSM-IV major depressive episode

2. Risk for recurrence in depression

3. The Clinical Course of Unipolar Major Depressive Disorders

4. The Epidemiology of Depression Across Cultures

5. Treatment-resistant depression: therapeutic trends, challenges, and future directions

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ketamine and Esketamine for Depression in Daily Practice;Journal of Clinical Psychopharmacology;2024-08-22

2. Relationships of depression and antidepressant use with epigenetic age acceleration and all-cause mortality among postmenopausal women;Aging;2024-05-27

3. Depressive symptoms and antidepressant use in relation to white blood cell count among postmenopausal women from the Women’s Health Initiative;Translational Psychiatry;2024-03-21

4. Oral ketamine may offer a solution to the ketamine conundrum;Psychopharmacology;2023-10-26

5. Reduction in Cognitive Symptoms Following Intranasal Esketamine Administration in Patients With Chronic Treatment-resistant Depression: A 12-Week Case Series;Journal of Psychiatric Practice;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3